Balchem ​​Corporation Announces Quarterly Second Quarter Financial Results Conference Call on… | New

NEW HAMPTON, NY, July 15 28, 2022 (GLOBE NEWSWIRE) — Balchem ​​Corporation (NASDAQ: BCPC) announced today that a conference call will be held Friday, July 29 at 11:00 a.m. Eastern Time (ET) to review the second quarter results. Ted Harris, Chairman, CEO and President, and Martin Bengtsson, Chief Financial Officer, will host the call.

Second quarter results will be released prior to market open on Friday, July 29, 2022. The press release and accompanying financial appendices will also be available on the Company’s website, www.balchem.com, prior to the conference call.

We invite you to listen to the conference call by dialing toll-free at 1-877-407-8289 (local call 1-201-689-8341), five minutes before the scheduled start time of the conference call. The conference call will be available for replay two hours after the call ends until the end of the day on Friday, August 12, 2022. To access the replay of the conference call, dial 1-877-660-6853 ( local call 1 -201-612-7415), and use conference ID #13731403.

About Balchem ​​Corporation

Balchem ​​Corporation develops, manufactures and markets specialty ingredients that enhance and enhance the health and well-being of life on the planet, providing cutting-edge solutions and the highest quality products for a range of industries in the whole world. The Company reports three business segments: Human Nutrition and Health; animal nutrition and health; and specialty products. The Human Nutrition & Health segment provides customized food and beverage ingredient systems and key nutrients in a variety of applications in the food, supplement and pharmaceutical industries. The Animal Nutrition and Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem ​​provides specialty packaged chemicals for use in healthcare and other industries, and also supplies chelated minerals to the agricultural micronutrient market.

Copyright 2022 GlobeNewswire, Inc.

Michael P. Boser